Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)
Abrisqueta, P., González-Barca, E., Ferrà, C., Ríos-Herranz, E., Fernández de la Mata, M., Delgado, J., Andreu, R., Hernández-Rivas, J. Á., … Read More